SUB Q SR90107A/ORG31540 IN DVT AFTER HIP REPLACEMENT

SUB Q SR90107A/ORG31540 髋关节置换术后深静脉血栓

• 批准号: 6279323
• 负责人: CLIFFORD W COLWELL
• 金额: $ 2.73万
• 依托单位: SCRIPPS RESEARCH INSTITUTE, THE
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6279323
• 关键词: clinical research; drug administration routes; drug adverse effect; drug screening /evaluation; fibrinolytic agents; fibrinolytic therapy; hip prosthesis; human subject; human therapy evaluation; postoperative complications; venous thrombosis

This site enrolled a total of 6 patients. Two patients had serious adverse events, inlcuding a major bleeding event probably related to study medication, the other was bacteremia unrelated to study drug. Both doses of the study medication were removed from the protocol and the study sponsor, Sanofi, closed enrollment with 935 patients enrolled over all sites.

本网站共招收6名患者。两名患者患有严重的 不良事件，包括可能与以下因素有关的重大出血事件 研究用药，另一种是与研究用药无关的菌血症。 研究中的两种剂量的药物都从方案中删除了 研究赞助商赛诺菲结束了935名患者的登记 在所有地点。